Search

Champions Oncology Inc

Suletud

SektorTervishoid

4.98 -1.97

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

4.75

Max

5.26

Põhinäitajad

By Trading Economics

Sissetulek

241K

-426K

Müük

1.4M

15M

P/E

Sektori keskmine

35.118

56.432

Aktsiakasum

-0.03

Kasumimarginaal

-2.797

Töötajad

214

EBITDA

79K

-95K

Dividendid

By Acuity

Järgmine tulemuste avaldamine

14. dets 2026

Turustatistika

By TradingEconomics

Turukapital

-4M

68M

Eelmine avamishind

6.95

Eelmine sulgemishind

4.98

Uudiste sentiment

By Acuity

50%

50%

120 / 339 Pingereas Healthcare

Champions Oncology Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

18. sept 2026, 20:02 UTC

Champions Oncology Inc shares fell slightly, continuing a downward trend since Thursday, despite an early recovery during Friday's trading session.

17. sept 2026, 20:01 UTC

News

Champions Oncology reported record annual revenue of $59.4 million for fiscal 2026, with shares trading higher amid a positive adjusted EBITDA of $1.6 million.

16. sept 2026, 19:06 UTC

Champions Oncology Inc is trading higher, experiencing significant volatility with a sharp midday rise after an initial dip, contrasting with three prior sessions that closed lower.

15. sept 2026, 20:03 UTC

News

Champions Oncology reports a net loss of $426,000 and revenue of $15.2 million. Shares are lower amid broader market declines following weak manufacturing data.

11. sept 2026, 19:56 UTC

News

Champions Oncology reported Q1 fiscal 2027 revenue of $15.2 million. Shares are lower despite improved gross margin and adjusted EBITDA of approximately $700,000.

10. sept 2026, 20:01 UTC

Champions Oncology Inc shares are higher today, continuing upward momentum after three consecutive sessions of decline. The stock remains above its 20-day moving average.

9. sept 2026, 20:07 UTC

Champions Oncology Inc shares declined for a fourth straight day, reaching a session low earlier. No specific news was identified to explain the movement.

8. sept 2026, 20:13 UTC

Champions Oncology Inc shares are lower in after-market hours, continuing a trend of declining performance over the past three sessions.

4. sept 2026, 19:07 UTC

Champions Oncology Inc is trading lower after reversing early gains, reflecting a decline since Thursday's close amid unchanged unemployment rates and decelerating wage growth.

3. sept 2026, 20:01 UTC

Champions Oncology Inc shares are higher today, maintaining strong upward momentum since Wednesday's close, despite no specific news to explain the movement.

2. sept 2026, 20:08 UTC

Champions Oncology Inc shares are higher today, breaking from a recent pattern of daily gains. No specific news was identified to explain the movement.

28. aug 2026, 19:36 UTC

Champions Oncology Inc. shares are trading roughly flat, with no specific news identified. The stock remains near the lower end of its one-month range.

27. aug 2026, 20:03 UTC

Champions Oncology shares are higher Thursday, reflecting a broader market trend amid declining initial jobless claims reported by the Labor Department.

25. aug 2026, 19:16 UTC

Champions Oncology Inc. is trading higher today, despite a flat performance and remaining below its 20-day moving average. No specific news was identified.

24. aug 2026, 20:06 UTC

News

Champions Oncology reports gross revenue of $59.42 million, with shares declining since Friday's close despite an earlier session increase.

21. aug 2026, 20:06 UTC

Champions Oncology Inc shares are lower in Friday's session amid broader market declines, with no specific news identified to explain the volatility.

20. aug 2026, 19:31 UTC

Champions Oncology Inc is higher today, driven by gains in the Life Sciences Tools & Services sub-sector, despite earlier session declines.

19. aug 2026, 20:02 UTC

Champions Oncology Inc shares declined during Wednesday's session, reaching a low in late morning amid no specific news to explain the downturn.

18. aug 2026, 19:41 UTC

Champions Oncology Inc shares are higher today, despite no specific news. Broader market concerns include inflation and rising treasury yields affecting investor sentiment.

17. aug 2026, 19:36 UTC

Champions Oncology Inc's shares are higher during Monday's session, reflecting a modest increase since Friday's close. The stock remains below its 20-day moving average.

14. aug 2026, 20:02 UTC

Champions Oncology is trading lower, reflecting broader market sentiment amid a surprising decline in U.S. retail sales for July.

13. aug 2026, 19:26 UTC

Champions Oncology Inc shares are higher during Thursday's session, rebounding from an earlier dip despite remaining below the 20-day moving average.

12. aug 2026, 19:51 UTC

Champions Oncology Inc's shares are lower today, diverging from recent gains, with no specific news identified to explain the decline.

11. aug 2026, 19:41 UTC

Champions Oncology Inc shares are lower today amid no specific news. The stock remains below its 20-day moving average and near the month's low.

10. aug 2026, 19:31 UTC

Champions Oncology Inc shares are lower, continuing a decline since Friday's close. The stock remains near its one-month range's lower end.

7. aug 2026, 19:42 UTC

Champions Oncology Inc shares are higher, driven by gains in the Life Sciences Tools & Services sub-sector. Earlier, they pulled back from a session high.

6. aug 2026, 19:32 UTC

Champions Oncology Inc shares are lower, continuing a downward trend amid broader market concerns over inflation and Federal Reserve policy. No specific news was identified.

5. aug 2026, 19:31 UTC

Champions Oncology Inc shares are lower during Wednesday's session, reflecting significant volatility amid broader market conditions and a notable drop in crude oil prices.

4. aug 2026, 19:51 UTC

Champions Oncology Inc shares are lower today, influenced by a decline in the Life Sciences Tools & Services sub-sector. The stock remains below its 20-day moving average.

3. aug 2026, 20:13 UTC

Champions Oncology Inc shares are trading higher in after-market hours. Broader market momentum is supported by strong tech performances and positive sentiment ahead of economic data.

Võrdlus sarnastega

Hinnamuutus

Champions Oncology Inc Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

0

Osta

0

Hoia

0

Müü

Sentiment

By Acuity

120 / 339 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.